These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19487052)

  • 1. [Validity of the MONICA cardiovascular questionnaire compared with clinical records].
    Baena-Díez JM; Alzamora-Sas MT; Grau M; Subirana I; Vila J; Torán P; García-Navarro Y; Bermúdez-Chillida N; Alegre-Basagaña J; Viozquez-Meia M; Marrugat J
    Gac Sanit; 2009; 23(6):519-25. PubMed ID: 19487052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of drugs related to the treatment of diabetes mellitus and other cardiovascular risk factors in the Spanish population. The Di@bet.es study.
    Rojo-Martínez G; Valdés S; Colomo N; Lucena MI; Gaztambide S; Gomis R; Casamitjana R; Carmena R; Catalá M; Martínez-Larrad MT; Serrano-Ríos M; Castaño L; Vendrell J; Girbés J; Franch J; Vázquez JA; Mora-Peces I; Urrutia I; Pascual-Manich G; Ortega E; Menéndez E; Delgado E; Bordiú E; Castell C; López-Alba A; Goday A; Calle A; Bosch-Comas A; Soriguer F
    Rev Esp Cardiol (Engl Ed); 2013 Nov; 66(11):854-63. PubMed ID: 24773992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
    Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999.
    Critchley J; Liu J; Zhao D; Wei W; Capewell S
    Circulation; 2004 Sep; 110(10):1236-44. PubMed ID: 15337690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population survey of cardiovascular disease in elderly people: design, methods and prevalence results.
    Dewhurst G; Wood DA; Walker F; Lampe FC; Jeffreys M; Cooper M; Williams JD
    Age Ageing; 1991 Sep; 20(5):353-60. PubMed ID: 1755392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PREVENCAT study: control of cardiovascular risk in primary care].
    Alvarez-Sala LA; Suárez C; Mantilla T; Franch J; Ruilope LM; Banegas JR; Barrios V;
    Med Clin (Barc); 2005 Mar; 124(11):406-10. PubMed ID: 15799845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county.
    Tretli S; Lund-Larsen PG; Foss OP
    J Epidemiol Community Health; 1982 Dec; 36(4):269-73. PubMed ID: 7166682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of family history of lifestyle-related diseases on questionnaire.
    Saito T; Nanri S; Saito I
    Pediatr Int; 2009 Aug; 51(4):514-9. PubMed ID: 19674363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cardiovascular disease epidemiology and risk factors in primary care].
    Baena Díez JM; del Val García JL; Tomàs Pelegrina J; Martínez Martínez JL; Martín Peñacoba R; González Tejón I; Raidó Quintana EM; Pomares Sajkiewicz M; Altés Boronat A; Alvarez Pérez B; Piñol Forcadell P; Rovira España M; Oller Colom M
    Rev Esp Cardiol; 2005 Apr; 58(4):367-73. PubMed ID: 15847733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative accuracy of cardiovascular risk prediction methods in primary care patients.
    Jones AF; Walker J; Jewkes C; Game FL; Bartlett WA; Marshall T; Bayly GR
    Heart; 2001 Jan; 85(1):37-43. PubMed ID: 11119458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
    Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
    Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.
    Vanaclocha F; Belinchón I; Sánchez-Carazo JL; Rivera R; Carrascosa JM; Cea-Calvo L; Juliá B; Puig L
    Eur J Dermatol; 2014; 24(6):662-9. PubMed ID: 25333326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prevalence of angina and cardiovascular risk factors in the different autonomous communities of Spain: the PANES Study. Prevalencia de Angina en España].
    López-Bescós L; Cosín J; Elosua R; Cabadés A; de los Reyes M; Arós F; Diago JL; Asín E; Castro-Beiras A; Marrugat J
    Rev Esp Cardiol; 1999 Dec; 52(12):1045-56. PubMed ID: 10659650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
    Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
    Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
    Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-morbidity of 'clinical trial' versus 'real-world' patients using cardiovascular drugs.
    Wieringa NF; Vos R; van der Werf GT; van der Veen WJ; de Graeff PA
    Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):569-79. PubMed ID: 11338915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records.
    Klungel OH; de Boer A; Paes AH; Seidell JC; Bakker A
    Neth J Med; 1999 Oct; 55(4):177-83. PubMed ID: 10555434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.